123 related articles for article (PubMed ID: 12868572)
1. Liposome-encapsulated oxymorphone hydrochloride provides prolonged relief of postsurgical visceral pain in rats.
Krugner-Higby L; Smith L; Clark M; Heath TD; Dahly E; Schiffman B; Hubbard-VanStelle S; Ney D; Wendland A
Comp Med; 2003 Jun; 53(3):270-9. PubMed ID: 12868572
[TBL] [Abstract][Full Text] [Related]
2. A single dose of liposome-encapsulated oxymorphone or morphine provides long-term analgesia in an animal model of neuropathic pain.
Smith LJ; Krugner-Higby L; Clark M; Wendland A; Heath TD
Comp Med; 2003 Jun; 53(3):280-7. PubMed ID: 12868573
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of liposome-encapsulated oxymorphone hydrochloride in mice after splenectomy.
Clark MD; Krugner-Higby L; Smith LJ; Heath TD; Clark KL; Olson D
Comp Med; 2004 Oct; 54(5):558-63. PubMed ID: 15575370
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
[TBL] [Abstract][Full Text] [Related]
5. A comparison of two opioid analgesics for relief of visceral pain induced by intestinal resection in rats.
Gillingham MB; Clark MD; Dahly EM; Krugner-Higby LA; Ney DM
Contemp Top Lab Anim Sci; 2001 Jan; 40(1):21-6. PubMed ID: 11300671
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ketoprofen, oxymorphone hydrochloride, and butorphanol in the treatment of postoperative pain in dogs.
Pibarot P; Dupuis J; Grisneaux E; Cuvelliez S; Planté J; Beauregard G; Bonneau NH; Bouffard J; Blais D
J Am Vet Med Assoc; 1997 Aug; 211(4):438-44. PubMed ID: 9267504
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of oxymorphone extended release in postsurgical pain: a randomized clinical trial in knee arthroplasty.
Ahdieh H; Ma T; Babul N; Lee D
J Clin Pharmacol; 2004 Jul; 44(7):767-76. PubMed ID: 15199081
[TBL] [Abstract][Full Text] [Related]
8. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
Kivitz A; Ma C; Ahdieh H; Galer BS
Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
[TBL] [Abstract][Full Text] [Related]
9. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
Peniston JH; Gould E
Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
[TBL] [Abstract][Full Text] [Related]
10. Titration with oxymorphone extended release to achieve effective long-term pain relief and improve tolerability in opioid-naive patients with moderate to severe pain.
Rauck R; Ma T; Kerwin R; Ahdieh H
Pain Med; 2008 Oct; 9(7):777-85. PubMed ID: 18950436
[TBL] [Abstract][Full Text] [Related]
11. Sedative effects and serum drug concentrations of oxymorphone and metabolites after subcutaneous administration of a liposome-encapsulated formulation in dogs.
Smith LJ; Krugner-Higby L; Trepanier LA; Flaska DE; Joers V; Heath TD
J Vet Pharmacol Ther; 2004 Oct; 27(5):369-72. PubMed ID: 15500576
[No Abstract] [Full Text] [Related]
12. The pain quality response profile of oxymorphone extended release in the treatment of low back pain.
Gould EM; Jensen MP; Victor TW; Gammaitoni AR; White RE; Galer BS
Clin J Pain; 2009 Feb; 25(2):116-22. PubMed ID: 19333156
[TBL] [Abstract][Full Text] [Related]
13. A single dose of liposome-encapsulated hydromorphone provides extended analgesia in a rat model of neuropathic pain.
Smith LJ; Valenzuela JR; Krugner-Higby LA; Brown C; Heath TD
Comp Med; 2006 Dec; 56(6):487-92. PubMed ID: 17219779
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of oxymorphone immediate release for the treatment of mild to moderate pain after ambulatory orthopedic surgery: results of a randomized, double-blind, placebo-controlled trial.
Gimbel JS; Walker D; Ma T; Ahdieh H
Arch Phys Med Rehabil; 2005 Dec; 86(12):2284-9. PubMed ID: 16344024
[TBL] [Abstract][Full Text] [Related]
15. Effects of the opioid analgesic oxymorphone hydrochloride on reproductive function in male and female rats.
Shuey DL; Stump DG; Carliss RD; Gerson RJ
Birth Defects Res B Dev Reprod Toxicol; 2008 Feb; 83(1):12-8. PubMed ID: 18088051
[TBL] [Abstract][Full Text] [Related]
16. Oral oxymorphone (Opana).
Med Lett Drugs Ther; 2007 Jan; 49(1251):3-4. PubMed ID: 17179898
[No Abstract] [Full Text] [Related]
17. Are repeated doses of buprenorphine detrimental to postoperative recovery after laparotomy in rats?
Bomzon A
Comp Med; 2006 Apr; 56(2):114-8. PubMed ID: 16639978
[TBL] [Abstract][Full Text] [Related]
18. The analgesic efficacy and safety of intra-articular morphine and mepivicaine following temporomandibular joint arthroplasty.
Zuniga JR; Ibanez C; Kozacko M
J Oral Maxillofac Surg; 2007 Aug; 65(8):1477-85. PubMed ID: 17656271
[TBL] [Abstract][Full Text] [Related]
19. Long-term pain vulnerability after surgery in rats: prevention by nefopam, an analgesic with antihyperalgesic properties.
Laboureyras E; Chateauraynaud J; Richebé P; Simonnet G
Anesth Analg; 2009 Aug; 109(2):623-31. PubMed ID: 19608840
[TBL] [Abstract][Full Text] [Related]
20. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
Oifa S; Sydoruk T; White I; Ekstein MP; Marouani N; Chazan S; Skornick Y; Weinbroum AA
Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
